Fibroblast growth factor-2

International Journal of Biochemistry and Cell Biology

Volumn 32, Issue 2, 2000, Pages 115-120

  Nugent, Matthew A ^a   Iozzo, Renato V ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Fibroblast growth factor; Heparan sulfate; Proteoglycans

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HEPARAN SULFATE; HEPARIN; PROTEIN INHIBITOR; PROTEIN TYROSINE KINASE;

ADIPOSE TISSUE; ANGIOGENESIS; ATHEROSCLEROSIS; CANCER; DRUG ADMINISTRATION; ENZYME ACTIVITY; EPICARDIUM; HISTOGENESIS; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RECEPTOR BINDING; RESTENOSIS; REVIEW; WOUND HEALING;

EID: 0033989785     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(99)00123-5     Document Type: Article

References (15)

1. Bikfalvi A., Klein S., Pintucci G., Rifkin D.B. Biological roles of fibroblast growth factor-2. Endocr. Rev. 18:1997;26-45.
2. Gospodarowicz D. Purification of a fibroblast growth factor from bovine pituitary. J. Biol. Chem. 250:1975;2515-2520.
3. Faham S., Hileman R.E., Fromm J.R., Linhardt R.J., Rees D.C. Heparin structure and interactions with basic fibroblast growth factor. Science. 271:1996;1116-1120.
4. Conrad H.E. Heparin-binding Proteins. 1998;Academic Press, San Diego.
5. Iozzo R.V. Matrix proteoglycans: from molecular design to cellular function. Annu. Rev. Biochem. 67:1998;609-652.
6. Sharma B., Handler M., Eichstetter I., Whitelock J.M., Nugent M.A., Iozzo R.V. Antisense targeting of perlecan blocks tumor growth and angiogenesis in vivo. J. Clin. Invest. 102:1998;1599-1608.
7. Kan M., Wang F., Xu J., Crabb J.W., Hou J., McKeehan W.L. An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science. 259:(26):1993;1918-1921.
8. Yayon A., Klagsbrun M., Esko J.D., Leder P., Ornitz D.M. Cell surface, heparin-like molecules are required for binding basic fibroblast growth factor to its high affinity receptor. Cell. 64:1991;841-848.
9. Folkman J., Klagsbrun M., Sasse J., Wadzinski M., Ingber D., Vlodavsky I. Heparin-binding angiogenic protein-basic fibroblast growth factor is stored within basement membrane. Am. J. Pathol. 130:1988;393-400.
10. Dowd C.J., Cooney C.L., Nugent M.A. Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. J. Biol. Chem. 274:1999;5236-5244.
11. Sperinde G.V., Nugent M.A. Heparan sulfate proteoglycans control bFGF processing in vascular smooth muscle cells. Biochemistry. 37:1998;13153-13164.
12. Fannon M., Nugent M.A. FGF binds its receptors, is internalized and stimulates DNA synthesis in Balb/c3T3 cells the absence of heparan sulfate. J. Biol. Chem. 271:1996;17949-17956.
13. Reiland J., Rapraeger A.C. Heparan sulfate proteoglycan and FGF receptor target basic FGF to different intracellular destinations. J. Cell Sci. 105:1993;1085-1093.
14. Horowitz A., Simons M. Regulation of syndecan-4 phosphorylation in vivo. J. Biol. Chem. 273:1998;10914-10918.
15. Sellke F.W., Laham R.J., Edelman E.R., Pearlman J.D., Simons M. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann. Thorac. Surg. 65:1998;1540-1544.